Item 2.02. Results of Operations and Financial Condition.
OnJanuary 10, 2022 ,NewAge, Inc. (the "Company") issued a press release regarding its preliminary financial results for the three months endedDecember 31, 2021 . A copy of the press release is furnished as Exhibit 99.1. The information contained in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. OnJanuary 10, 2022 , the board of directors (the "Board") of the Company andBrent Willis , Chief Executive Officer, agreed thatMr. Willis will resign as Chief Executive Officer, Director, and employee of the Company, effective immediately. The Company andMr. Willis will determine the terms of his departure at a future date. The Company intends to begin a search for a new Chief Executive Officer promptly. No replacement has been appointed to serve as the Company's principal executive officer during the transition period. The Company expects that, during this period, the Company's Board will make all principal executive officer-level determinations andEd Brennan , the independent Chairman of the Board, will provide additional guidance and direction to the senior management team on behalf of the Board during this period.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year. OnJanuary 6, 2022 , the Board amended the Company's bylaws to permit special meetings of the Board to be held on less than 48 hours' notice by the Chair if a majority of the entire Board at the special meeting ratifies the notice of such special meeting. A copy of the amendment to the bylaws is filed as Exhibit 3.1.
Item 7.01 Regulation FD Disclosure.
On
The presentation can be accessed at https://wsw.com/webcast/icr7/register.aspx?conf=icr7&page=nbev&url=https://wsw.com/webcast/icr7/nbev/1596967 and on the Conference Calls page of the Company's Investor Relations website at https://newagegroup.com/investors. A copy of the press release is furnished as Exhibit 99.2. The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.2, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 3.1 Amendment to the Company's Bylaws 99.1 Press Release datedJanuary 10, 2022 regarding Preliminary Financial Results 99.2 Press Release datedJanuary 10, 2022 regardingICR Conference 104 Cover Page Interactive Data File, formatted in Inline XBRL
© Edgar Online, source